vs
Side-by-side financial comparison of NCR Atleos Corp (NATL) and PERRIGO Co plc (PRGO). Click either name above to swap in a different company.
NCR Atleos Corp is the larger business by last-quarter revenue ($1.2B vs $1.1B, roughly 1.0× PERRIGO Co plc). NCR Atleos Corp runs the higher net margin — 7.2% vs -127.8%, a 135.0% gap on every dollar of revenue. On growth, NCR Atleos Corp posted the faster year-over-year revenue change (4.0% vs -2.5%). NCR Atleos Corp produced more free cash flow last quarter ($194.0M vs $148.6M). Over the past eight quarters, NCR Atleos Corp's revenue compounded faster (4.9% CAGR vs 1.3%).
NCR Voyix Corporation, previously known as NCR Corporation and National Cash Register, is a global software, consulting and technology company providing several professional services and electronic products. It manufactured self-service kiosks, point-of-sale terminals, automated teller machines, check processing systems, and barcode scanners.
Perrigo Company plc is an American Irish-registered manufacturer of private label over-the-counter pharmaceuticals, and while 70% of Perrigo's net sales are from the U.S. healthcare system, Perrigo is legally headquartered in Ireland for tax purposes, which accounts for 0.60% of net sales. In 2013, Perrigo completed the sixth-largest US corporate tax inversion in history when it reregistered its tax status to Ireland to avoid U.S. corporate taxes. Perrigo maintains its corporate headquarters ...
NATL vs PRGO — Head-to-Head
Income Statement — Q4 FY2025 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $1.2B | $1.1B |
| Net Profit | $83.0M | $-1.4B |
| Gross Margin | — | 32.6% |
| Operating Margin | 13.5% | -116.0% |
| Net Margin | 7.2% | -127.8% |
| Revenue YoY | 4.0% | -2.5% |
| Net Profit YoY | 102.4% | -3093.9% |
| EPS (diluted) | $1.09 | $-10.23 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $1.2B | $1.1B | ||
| Q3 25 | $1.1B | $1.0B | ||
| Q2 25 | $1.1B | $1.1B | ||
| Q1 25 | $979.0M | $1.0B | ||
| Q4 24 | $1.1B | $1.1B | ||
| Q3 24 | $1.1B | $1.1B | ||
| Q2 24 | $1.1B | $1.1B | ||
| Q1 24 | $1.0B | $1.1B |
| Q4 25 | $83.0M | $-1.4B | ||
| Q3 25 | $26.0M | $7.5M | ||
| Q2 25 | $39.0M | $-8.4M | ||
| Q1 25 | $14.0M | $-6.4M | ||
| Q4 24 | $41.0M | $-44.4M | ||
| Q3 24 | $21.0M | $-21.0M | ||
| Q2 24 | $27.0M | $-108.4M | ||
| Q1 24 | $-9.0M | $2.0M |
| Q4 25 | — | 32.6% | ||
| Q3 25 | — | 36.1% | ||
| Q2 25 | — | 34.4% | ||
| Q1 25 | — | 37.6% | ||
| Q4 24 | — | 33.9% | ||
| Q3 24 | — | 37.2% | ||
| Q2 24 | — | 37.0% | ||
| Q1 24 | — | 33.1% |
| Q4 25 | 13.5% | -116.0% | ||
| Q3 25 | 9.8% | 7.0% | ||
| Q2 25 | 10.8% | 4.3% | ||
| Q1 25 | 9.5% | 4.5% | ||
| Q4 24 | 13.4% | 10.0% | ||
| Q3 24 | 10.6% | 7.4% | ||
| Q2 24 | 9.8% | -2.5% | ||
| Q1 24 | 6.5% | -5.1% |
| Q4 25 | 7.2% | -127.8% | ||
| Q3 25 | 2.3% | 0.7% | ||
| Q2 25 | 3.5% | -0.8% | ||
| Q1 25 | 1.4% | -0.6% | ||
| Q4 24 | 3.7% | -3.9% | ||
| Q3 24 | 2.0% | -1.9% | ||
| Q2 24 | 2.5% | -10.2% | ||
| Q1 24 | -0.9% | 0.2% |
| Q4 25 | $1.09 | $-10.23 | ||
| Q3 25 | $0.34 | $0.05 | ||
| Q2 25 | $0.52 | $-0.06 | ||
| Q1 25 | $0.19 | $-0.05 | ||
| Q4 24 | $0.56 | $-0.32 | ||
| Q3 24 | $0.28 | $-0.15 | ||
| Q2 24 | $0.37 | $-0.79 | ||
| Q1 24 | $-0.13 | $0.01 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $456.0M | — |
| Total DebtLower is stronger | $2.7B | — |
| Stockholders' EquityBook value | $403.0M | $2.9B |
| Total Assets | $5.7B | $8.5B |
| Debt / EquityLower = less leverage | 6.63× | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $456.0M | — | ||
| Q3 25 | $412.0M | $432.1M | ||
| Q2 25 | $357.0M | $454.2M | ||
| Q1 25 | $352.0M | $409.9M | ||
| Q4 24 | $419.0M | $558.8M | ||
| Q3 24 | $395.0M | $1.5B | ||
| Q2 24 | $374.0M | $542.8M | ||
| Q1 24 | $343.0M | $658.5M |
| Q4 25 | $2.7B | — | ||
| Q3 25 | $2.8B | — | ||
| Q2 25 | $2.8B | — | ||
| Q1 25 | — | — | ||
| Q4 24 | $2.9B | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
| Q4 25 | $403.0M | $2.9B | ||
| Q3 25 | $330.0M | $4.4B | ||
| Q2 25 | $350.0M | $4.5B | ||
| Q1 25 | $275.0M | $4.4B | ||
| Q4 24 | $219.0M | $4.3B | ||
| Q3 24 | $264.0M | $4.6B | ||
| Q2 24 | $250.0M | $4.5B | ||
| Q1 24 | $283.0M | $4.7B |
| Q4 25 | $5.7B | $8.5B | ||
| Q3 25 | $5.7B | $10.1B | ||
| Q2 25 | $5.8B | $10.1B | ||
| Q1 25 | $5.7B | $9.8B | ||
| Q4 24 | $5.5B | $9.6B | ||
| Q3 24 | $5.7B | $11.2B | ||
| Q2 24 | $5.8B | $10.4B | ||
| Q1 24 | $5.8B | $10.6B |
| Q4 25 | 6.63× | — | ||
| Q3 25 | 8.45× | — | ||
| Q2 25 | 8.05× | — | ||
| Q1 25 | — | — | ||
| Q4 24 | 13.05× | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $231.0M | $175.4M |
| Free Cash FlowOCF − Capex | $194.0M | $148.6M |
| FCF MarginFCF / Revenue | 16.8% | 13.4% |
| Capex IntensityCapex / Revenue | 3.2% | 2.4% |
| Cash ConversionOCF / Net Profit | 2.78× | — |
| TTM Free Cash FlowTrailing 4 quarters | $239.0M | $145.1M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $231.0M | $175.4M | ||
| Q3 25 | $25.0M | $51.7M | ||
| Q2 25 | $-23.0M | $75.9M | ||
| Q1 25 | $123.0M | $-64.5M | ||
| Q4 24 | $80.0M | $312.6M | ||
| Q3 24 | $107.0M | $42.2M | ||
| Q2 24 | $9.0M | $9.5M | ||
| Q1 24 | $148.0M | $-1.4M |
| Q4 25 | $194.0M | $148.6M | ||
| Q3 25 | $-5.0M | $29.8M | ||
| Q2 25 | $-44.0M | $56.7M | ||
| Q1 25 | $94.0M | $-90.0M | ||
| Q4 24 | $62.0M | $274.9M | ||
| Q3 24 | $85.0M | $15.1M | ||
| Q2 24 | $-14.0M | $-18.9M | ||
| Q1 24 | $124.0M | $-26.5M |
| Q4 25 | 16.8% | 13.4% | ||
| Q3 25 | -0.4% | 2.9% | ||
| Q2 25 | -4.0% | 5.4% | ||
| Q1 25 | 9.6% | -8.6% | ||
| Q4 24 | 5.6% | 24.2% | ||
| Q3 24 | 7.9% | 1.4% | ||
| Q2 24 | -1.3% | -1.8% | ||
| Q1 24 | 11.9% | -2.4% |
| Q4 25 | 3.2% | 2.4% | ||
| Q3 25 | 2.7% | 2.1% | ||
| Q2 25 | 1.9% | 1.8% | ||
| Q1 25 | 3.0% | 2.4% | ||
| Q4 24 | 1.6% | 3.3% | ||
| Q3 24 | 2.1% | 2.5% | ||
| Q2 24 | 2.1% | 2.7% | ||
| Q1 24 | 2.3% | 2.3% |
| Q4 25 | 2.78× | — | ||
| Q3 25 | 0.96× | 6.89× | ||
| Q2 25 | -0.59× | — | ||
| Q1 25 | 8.79× | — | ||
| Q4 24 | 1.95× | — | ||
| Q3 24 | 5.10× | — | ||
| Q2 24 | 0.33× | — | ||
| Q1 24 | — | -0.70× |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
NATL
| Services | $848.0M | 74% |
| APJ | $136.0M | 12% |
| Americas Excluding United States | $135.0M | 12% |
| TT | $44.0M | 4% |
PRGO
| Consumer Self Care Americas | $697.0M | 63% |
| Digestive Health | $123.9M | 11% |
| Nutrition | $108.3M | 10% |
| Healthy Lifestyle | $94.8M | 9% |
| Pain And Sleep Aids | $87.1M | 8% |
